Liver Function Assessment - Feasibility and Dosing Study
Status:
Terminated
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to 1) determine the feasibility of using Cardiox Liver Function
Assessment System (LFA) to measure indocyanine green (ICG) clearance; 2) determine an
adequate dose based on LFA technology and 3) determine an adequate time period for LFA
determination.